Cellebrite DI Ltd.
David Barter (Chief Financial Officer) sells CLBT shares
About this filing
Cellebrite DI Ltd. (CLBT) filed Form 4 (insider transaction) with the SEC on Oct 19, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- David Barter · Chief Financial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | S · open-market saleFootnotes F1, F2 | −12,134 | $11.21 | $136,069.46 | 322,085 | Direct |
Footnotes
- F1 The shares reported as disposed herein were granted on July 7, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
- F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.07 to $11.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
More CLBT filings
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- SC 13G
Filed Oct 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.